Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | 4-Nitrophenyl chloroformate | HCID 82129 | — |
| Reactant | ethyl 1-[(R)-2-amino-3-(3,4-dichlorophenyl)propionyl]-4-cyclohexylpiperidine-4-carboxylate | HCID 66987715 | — |
| Reactant | HCID 178419017 | HCID 178419017 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 178468420 | HCID 178468420 | 38% |
Reaction Steps
60 mg (11 mmol) of ethyl 1-[(R)-2-amino-3-(3,4-dichlorophenyl)propionyl]-4-cyclohexylpiperidine-4-carboxylate and 29 mg (0.12 mmol) of para-nitrophenyl chloroformate are dissolved in 5 ml of dichloromethane. The mixture is stirred for 1 hour at room temperature and the solution is then poured into water and extracted with dichloromethane. The organic phase is dried over sodium sulfate, filtered and concentrated. The colourless oil obtained is diluted in 5 ml of dimethylformamide, the mixture is heated to 80° C., and 18 mg (0.12 mmol) of histamine are added and the solution is stirred for 5 minutes at 80° C. and overnight at room temperature. The reaction is stopped by adding aqueous 1N sodium hydroxide solution and the organic compounds are extracted with dichloromethane. The organic phase is washed with water and then dried over sodium sulfate, filtered and concentrated. The oil obtained is chromatographed on silica gel (eluent: 90/10 DCM/MeOH). 25 mg of ethyl 4-cyclohexyl-1-((R)-3-(3,4-dichlorophenyl)-2-{3-[2-(1H-imidazol-4-yl)ethyl]ureido}-propionyl)piperidine-4-carboxylate in the form of a colourless oil are obtained in a yield of 38%.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08962846B2 |
|---|
| Source dataset | uspto-grants-2015_02 |
|---|
| ORD ID | ord-d9a65fc73684467ab6f8ffaab11beac6 |
|---|
| Source note | uspto-grants-2015_02 |
|---|